Robeco Institutional Asset Management B.V. boosted its holdings in shares of Xylem Inc. (NYSE:XYL – Free Report) by 8.4% in the third quarter, according to its most recent filing with the SEC. The firm owned 199,838 shares of the industrial products company’s stock after acquiring an additional 15,472 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Xylem were worth $29,476,000 as of its most recent filing with the SEC.
A number of other large investors also recently made changes to their positions in the stock. AQR Capital Management LLC increased its holdings in Xylem by 14.4% in the first quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company’s stock valued at $3,645,000 after purchasing an additional 3,900 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Xylem by 9.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 44,750 shares of the industrial products company’s stock worth $5,346,000 after buying an additional 4,021 shares during the period. NewEdge Advisors LLC increased its stake in shares of Xylem by 3.3% in the 1st quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company’s stock valued at $496,000 after acquiring an additional 132 shares during the last quarter. Ashton Thomas Private Wealth LLC raised its position in shares of Xylem by 55.3% in the 1st quarter. Ashton Thomas Private Wealth LLC now owns 5,781 shares of the industrial products company’s stock valued at $691,000 after acquiring an additional 2,058 shares during the period. Finally, Fred Alger Management LLC acquired a new stake in shares of Xylem in the 1st quarter valued at approximately $439,000. Institutional investors and hedge funds own 87.96% of the company’s stock.
Xylem Trading Down 1.3%
NYSE:XYL opened at $139.46 on Thursday. The company has a market cap of $33.95 billion, a P/E ratio of 35.85, a price-to-earnings-growth ratio of 2.00 and a beta of 1.17. Xylem Inc. has a twelve month low of $100.47 and a twelve month high of $154.27. The business has a 50 day moving average price of $141.52 and a two-hundred day moving average price of $140.53. The company has a quick ratio of 1.50, a current ratio of 1.96 and a debt-to-equity ratio of 0.17.
Xylem Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 23rd. Stockholders of record on Tuesday, November 25th were issued a $0.40 dividend. The ex-dividend date was Tuesday, November 25th. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. Xylem’s dividend payout ratio (DPR) is presently 41.13%.
Insider Activity
In related news, Director Victoria D. Harker sold 1,700 shares of Xylem stock in a transaction dated Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total value of $251,838.00. Following the sale, the director owned 16,875 shares of the company’s stock, valued at approximately $2,499,862.50. The trade was a 9.15% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Claudia S. Toussaint sold 10,421 shares of the company’s stock in a transaction dated Thursday, October 30th. The stock was sold at an average price of $152.64, for a total value of $1,590,661.44. Following the sale, the executive vice president owned 31,250 shares in the company, valued at $4,770,000. The trade was a 25.01% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.27% of the stock is owned by company insiders.
Analysts Set New Price Targets
Several equities research analysts have commented on XYL shares. Royal Bank Of Canada upped their target price on shares of Xylem from $169.00 to $176.00 and gave the company an “outperform” rating in a research note on Wednesday, October 29th. Barclays decreased their price objective on Xylem from $172.00 to $166.00 and set an “overweight” rating for the company in a research report on Wednesday. Citigroup raised their target price on shares of Xylem from $173.00 to $182.00 and gave the stock a “buy” rating in a report on Wednesday, October 29th. UBS Group lifted their price target on shares of Xylem from $168.00 to $175.00 and gave the company a “buy” rating in a research note on Thursday, November 6th. Finally, Stifel Nicolaus increased their price objective on shares of Xylem from $175.00 to $178.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. Eight research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $165.80.
Check Out Our Latest Analysis on Xylem
Xylem Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Read More
- Five stocks we like better than Xylem
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- Wall Street ‘Sleeper Stock’ Could Become #1 Stock of 2026
- YDES Could Be 2026’s Biotech Breakthrough
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
